GSTO2 and amyotrophic lateral sclerosis: In addition, GstO2 was capable of reducing both the degenerative and defective phenotypes, and markedly decreased intracellular ROS generation, thus suggesting GstO2 as a key regulator of hTDP-43-related ALS pathogenesis [172].